Hutch News

Hutch News

Stories tagged 'financial toxicity'

Blood clots: What cancer patients need to know

A common side effect of cancer and its treatment gets renewed attention and potential new therapies

March 29, 2019 | By Diane Mapes / Fred Hutch News Service

Blood clots can be a common – and even deadly – side effect of both cancer and its treatment. Fred Hutch's Dr. Gary Lyman, an expert in blood clots (also known as thrombi) is helping set national policy on how blood clots can be prevented in order to reduce medical costs and save patient lives.

View story >


Dr. Veena Shankaran named 2019 Leader in Health Care

Seattle Business magazine honors oncologist, health services researcher

March 1, 2019 | By Susan Keown / Fred Hutch News Service

Seattle Business magazine honors oncologist, health services researcher for her national leadership in studying the "financial toxicity" of cancer treatment.

View story >


Biologics and biosimilars step onto the cancer therapy stage

Q&A: Oncologist and health economist Dr. Gary Lyman discusses a class of treatments on the rise. Will prices follow?

May 31, 2018 | By Diane Mapes / Fred Hutch News Service

Costly biologics and their "generic-ish" counterparts, biosimilars, are about to step into the pharmaceutical spotlight in a big way. We sat down with Fred Hutch's Dr. Gary Lyman, an oncologist and national thought leader on health economics, to learn more about burgeoning biopharmaceuticals.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.